AKAM vs ATNM · P/E 27, rev $2.17B vs rev $35.0M
Akamai Technologies Inc (AKAM) versus Actinium Pharmaceuticals Inc (ATNM) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. ATNM currently screens at market cap $33.9M.
Not investment advice. Open the AKAM and ATNM stock pages for the full models.
Not investment advice.